Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries.

Mahmud, Sarwat; Baral, Ranju; Sanderson, Colin; Pecenka, Clint; Jit, Mark; Li, You; Clark, Andrew; (2023) Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries. BMC medicine, 21 (1). 138-. ISSN 1741-7015 DOI: https://doi.org/10.1186/s12916-023-02827-5

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/s12916-023-02827-5

Abstract

Share

Download

Filename: Mahmud-etal-2023-Cost-effectiveness-of-pharmaceutical-strategies.pdf

Licence: Creative Commons: Attribution 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar